GlassScriptPhysician profile
Jason C Friedrichs
NPI 1962610642
$8,118.75
in general payments reported to CMS, 2019-2025
17 companies · $2,762 in 2025
The $2,762 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.91 · 2020: $131 · 2021: $282 · 2022: $1,876 · 2023: $975 · 2024: $2,037 · 2025: $2,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,547 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Education: $27.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,547.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Education | $27.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $4,952.99 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $805.05 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $731.10 | 2022-2025 | Envista Envy Iol, Stellaris, Miebo |
| Biotissue Holdings INC. | $294.01 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $252.40 | 2022-2025 | Veritas Vision System, Tecnis Iol |
| Rxsight INC | $242.77 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Alcon Vision LLC | $169.88 | 2019-2025 | Clareon |
| Allergan, INC. | $148.97 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.35 | 2021 | |
| Glaukos Corporation | $99.28 | 2022-2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Ocular Therapeutix, INC. | $87.05 | 2024-2025 | Dextenza |
| Thrombogenics, INC. | $80.18 | 2020 | |
| Ivantis, INC | $50.33 | 2020 | |
| Harrow Eye, LLC | $36.19 | 2024-2025 | Vevye |
| Regeneron Healthcare Solutions, INC. | $29.31 | 2024 | Eylea Hd, Eylea |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $23.01 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Friedrichs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.